Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ding Yu

Showing results (281-290 of 315) with videos related to

Pageof 32
Sort By:
Frontiers in Pharmacology|April 21, 2020
The Use of Peripheral Blood-Derived Stem Cells for Cartilage Repair and Regeneration <i>In Vivo</i>: A ReviewYou-Rong Chen, Xin Yan, Fu-Zhen Yuan, et al.
Plos One|November 9, 2013
A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1Davide Danovi, Amos Folarin, Sabine Gogolok, et al.
Molecular Psychiatry|March 28, 2026
ATP release from the amygdala-prefrontal pathway regulates vulnerability to social stress in male miceDing-Yu Wu, Jian-Lin Wu, Hao Chen, et al.
Nature Communications|June 1, 2021
Impaired calcium signaling in astrocytes modulates autism spectrum disorder-like behaviors in miceQian Wang, Ying Kong, Ding-Yu Wu, et al.
Immunity|October 31, 2020
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19Ting Shu, Wanshan Ning, Di Wu, et al.
National Science Review|October 22, 2021
Plasma metabolomic and lipidomic alterations associated with COVID-19Di Wu, Ting Shu, Xiaobo Yang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 24, 2025
ATP Release Deficiency through Astrocytic Connexin 43 in the Dorsal Hippocampus Promotes Depressive- and Anxiety-Like BehaviorsMeng-Ling Wang, Jian Hu, Yue-Xin Wang, et al.
BMC Cancer|January 24, 2024
Long-term outcomes with HLX01 (HanliKang<sup>®</sup>), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 studyYan Qin, Yongping Song, Dong Wang, et al.
Cancer|January 3, 2025
Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trialYan Gao, Yunhong Huang, Qingyuan Zhang, et al.
Chest|March 11, 2026
Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients with COPD in China (PACER-II): a phase 2, multicentre, randomised, double-blind, placebo-controlled trialLi-Xiu He, Ling Yang, Zu-Ke Xiao, et al.
Pageof 32

Showing results (281-290 of 315) with videos related to

Sort By:
Pageof 32
Frontiers in Pharmacology|April 21, 2020
The Use of Peripheral Blood-Derived Stem Cells for Cartilage Repair and Regeneration <i>In Vivo</i>: A ReviewYou-Rong Chen, Xin Yan, Fu-Zhen Yuan, et al.
Plos One|November 9, 2013
A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1Davide Danovi, Amos Folarin, Sabine Gogolok, et al.
Molecular Psychiatry|March 28, 2026
ATP release from the amygdala-prefrontal pathway regulates vulnerability to social stress in male miceDing-Yu Wu, Jian-Lin Wu, Hao Chen, et al.
Nature Communications|June 1, 2021
Impaired calcium signaling in astrocytes modulates autism spectrum disorder-like behaviors in miceQian Wang, Ying Kong, Ding-Yu Wu, et al.
Immunity|October 31, 2020
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19Ting Shu, Wanshan Ning, Di Wu, et al.
National Science Review|October 22, 2021
Plasma metabolomic and lipidomic alterations associated with COVID-19Di Wu, Ting Shu, Xiaobo Yang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 24, 2025
ATP Release Deficiency through Astrocytic Connexin 43 in the Dorsal Hippocampus Promotes Depressive- and Anxiety-Like BehaviorsMeng-Ling Wang, Jian Hu, Yue-Xin Wang, et al.
BMC Cancer|January 24, 2024
Long-term outcomes with HLX01 (HanliKang<sup>®</sup>), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 studyYan Qin, Yongping Song, Dong Wang, et al.
Cancer|January 3, 2025
Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trialYan Gao, Yunhong Huang, Qingyuan Zhang, et al.
Chest|March 11, 2026
Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients with COPD in China (PACER-II): a phase 2, multicentre, randomised, double-blind, placebo-controlled trialLi-Xiu He, Ling Yang, Zu-Ke Xiao, et al.
Pageof 32